Skip to main content Accessibility help
×
Home

Letter to the Editor: Sodium nitroprusside for schizophrenia: could methodological variables account for the different results obtained?

  • J. P. Maia-de-Oliveira (a1) (a2) (a3), G. B. Baker (a2) (a4), S. M. Dursun (a2) (a4) and J. E. C. Hallak (a1) (a2)
  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Letter to the Editor: Sodium nitroprusside for schizophrenia: could methodological variables account for the different results obtained?
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Letter to the Editor: Sodium nitroprusside for schizophrenia: could methodological variables account for the different results obtained?
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Letter to the Editor: Sodium nitroprusside for schizophrenia: could methodological variables account for the different results obtained?
      Available formats
      ×

Abstract

  • An abstract is not available for this content so a preview has been provided below. To view the full text please use the links above to select your preferred format.

Copyright

Corresponding author

*Author for correspondence: J. P. Maia-de-Oliveira, M.D., M.Sc., Ph.D., Departamento de Neurociências e Ciências do Comportamento, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Hospital das Clínicas, Terceiro Andar, Av. Bandeirantes, 3900, Ribeirão Preto, São Paulo, Brazil. (Email: j.p@usp.br)

References

Hide All
Bech, P, Kastrup, M, Rafaelsen, OJ (1986). Mini-compendium of rating scales for states of anxiety, depression, mania schizophrenia, with corresponding DSM-III syndromes. Acta Psychiatrica Scandinavica Supplementum 326, 137.
Bujas-Bobanovic, M, Bird, DC, Robertson, HA, Dursun, SM (2000). Blockade of phencyclidine-induced effects by a nitric oxide donor. British Journal of Pharmacology 130, 10051012.
Csordas, A, Bernhard, D (2013). The biology behind the atherothrombotic effects of cigarette smoke. Nature Reviews Cardiology 10, 219230.
Guo, X, Oldham, MJ, Kleinman, MT, Phalen, RF, Kassab, GS (2006). Effect of cigarette smoking on nitric oxide, structural, and mechanical properties of mouse arteries. American Journal of Physiology – Heart and Circulatory Physiology 291, 23542361.
Hallak, JE, Maia-de-Oliveira, JP, Abrao, J, Evora, PR, Zuardi, AW, Crippa, JA, Belmonte-de-Abreu, P, Baker, GB, Dursun, SM (2013). Rapid improvement of acute schizophrenia symptoms after intravenous sodium nitroprusside: a randomized, double-blind, placebo-controlled trial. JAMA Psychiatry 70, 668676.
Kandratavicius, L, Balista, PA, Wolf, DC, Abrao, J, Evora, PR, Rodrigues, AJ, Chaves, C, Maia-de-Oliveira, JP, Leite, JP, Dursun, SM, Baker, GB, Guimaraes, FS, Hallak, JE (2015). Effects of nitric oxide-related compounds in the acute ketamine animal model of schizophrenia. BMC Neuroscience 16, 9.
Maia-de-Oliveira, JP, Abrao, J, Evora, PR, Zuardi, AW, Crippa, JA, Belmonte-de-Abreu, P, Baker, GB, Dursun, SM, Hallak, JE (2015 b). The effects of sodium nitroprusside treatment on cognitive deficits in schizophrenia: a pilot study. Journal of Clinical Psychopharmacology 35, 8385.
Maia-de-Oliveira, JP, Belmonte-de-Abreu, P, Bressan, RA, Cachoeira, C, Baker, GB, Dursun, SM, Hallak, JE (2014). Sodium nitroprusside treatment of clozapine-refractory schizophrenia. Journal of Clinical Psychopharmacology 34, 761763.
Maia-de-Oliveira, JP, Lobão-Soares, B, Ramalho, T, Gavioli, EC, Soares, VP, Teixeira, L, Baker, GB, Dursun, SM, Hallak, JE (2015 a). Nitroprusside single-dose prevents the psychosis-like behavior induced by ketamine in rats for up to one week. Schizophrenia Research 162, 211215.
Overall, JE, Goram, DR (1962). The brief psychiatric rating scale. Psychological Reports 10, 799812.
Pienaar, PR, Micklesfield, LK, Gill, JM, Shore, AC, Gooding, KM, Levitt, NS, Lambert, EV (2014). Ethnic differences in microvascular function in apparently healthy South African men and women. Experimental Physiology 99, 985994.
Stein, CM, Lang, CC, Nelson, R, Brown, M, Wood, AJ (1997). Vasodilation in black Americans: attenuated nitric oxide-mediated responses. Clinical Pharmacology and Therapeutics 62, 436443.
Stone, JM, Morrison, PD, Koychev, I, Gao, F, Reilly, TJ, Kolanko, M, Mohammadinasab, A, Kapur, S, McGuire, PK (2016). The effect of sodium nitroprusside on psychotic symptoms and spatial working memory in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial. Psychological Medicine. Published online 22 September 2016. doi:10.1017/S0033291716002245.
Trevlopoulou, A, Touzlatzi, N, Pitsikas, N (2016). The nitric oxide donor sodium nitroprusside attenuates recognition memory deficits and social withdrawal produced by the NMDA receptor antagonist ketamine and induces anxiolytic-like behaviour in rats. Psychopharmacology (Berlin) 233, 10451054.

Letter to the Editor: Sodium nitroprusside for schizophrenia: could methodological variables account for the different results obtained?

  • J. P. Maia-de-Oliveira (a1) (a2) (a3), G. B. Baker (a2) (a4), S. M. Dursun (a2) (a4) and J. E. C. Hallak (a1) (a2)

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed